Hepta Medical

HEPTA Medical is developing a unique minimally invasive, non-surgical treatment for early-stage lung cancer, enabling real-time, targeted, and adaptive ablation of lesions. It is also developing an endoscopically delivered ablation catheter that uses temperature-based feedback and real-time dosing to precisely target and ablate lung nodules without the need for surgery or radiation therapy.